Literature DB >> 9529361

A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene.

E Ars1, H Kruyer, A Gaona, P Casquero, J Rosell, V Volpini, E Serra, C Lázaro, X Estivill.   

Abstract

Spinal neurofibromatosis (SNF) has been considered to be an alternative form of neurofibromatosis in which spinal cord tumors are the main clinical characteristic. Familial SNF has been reported, elsewhere, in three families-two linked to markers within the gene for neurofibromatosis type 1 (NF1) and the other not linked to NF1-but no molecular alterations have been described in these families. We describe a three-generation family that includes five members affected by SNF. All the affected members presented multiple spinal neurofibromas and café au lait spots, one member had cutaneous neurofibromas, and some members had other signs of NF1. Genetic analysis, performed with markers within and flanking the NF1 gene, showed segregation with the NF1 locus. Mutation analysis, performed with the protein-truncation test and SSCP/heteroduplex analysis of the whole coding region of the NF1 gene, identified a frameshift mutation (8042insA) in exon 46, which should result in a truncated NF1 protein. The 8042insA mutation was detected in all five family members with the SNF/NF1 phenotype. To our knowledge, this is the first time that a mutation in the NF1 gene has been associated with SNF. The clinical homogeneity in the severity of the disease among the affected members of the family, which is unusual in NF1, suggests that a particular property of the NF1 mutation described here, a gene closely linked to NF1, or posttranscriptional events are involved in this severe neurological phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529361      PMCID: PMC1377042          DOI: 10.1086/301803

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  45 in total

1.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

2.  Highly polymorphic dinucleotide repeat at the NF2 gene.

Authors:  D Bourn; T Strachan
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

3.  A deletion in the 5'-region of the neurofibromatosis type 1 (NF1) gene.

Authors:  S Hoffmeyer; G Assum; D Kaufmann; K Schwenk; W Krone
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

4.  Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.

Authors:  K M Shannon; P O'Connell; G A Martin; D Paderanga; K Olson; P Dinndorf; F McCormick
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

5.  Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene.

Authors:  S D Colman; C A Williams; M R Wallace
Journal:  Nat Genet       Date:  1995-09       Impact factor: 38.330

6.  Noonan syndrome with café-au-lait spots and multiple lentigines syndrome are not linked to the neurofibromatosis type 1 locus.

Authors:  B E Ahlbom; N Dahl; P Zetterqvist; G Annerén
Journal:  Clin Genet       Date:  1995-08       Impact factor: 4.438

7.  Distribution of 13 truncating mutations in the neurofibromatosis 1 gene.

Authors:  R A Heim; L N Kam-Morgan; C G Binnie; D D Corns; M C Cayouette; R A Farber; A S Aylsworth; L M Silverman; M C Luce
Journal:  Hum Mol Genet       Date:  1995-06       Impact factor: 6.150

Review 8.  Neurofibromatosis type 1: pathology, clinical features and molecular genetics.

Authors:  A von Deimling; W Krone; A G Menon
Journal:  Brain Pathol       Date:  1995-04       Impact factor: 6.508

9.  Genomic organization of the neurofibromatosis 1 gene (NF1).

Authors:  Y Li; P O'Connell; H H Breidenbach; R Cawthon; J Stevens; G Xu; S Neil; M Robertson; R White; D Viskochil
Journal:  Genomics       Date:  1995-01-01       Impact factor: 5.736

10.  Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene.

Authors:  G Danglot; V Régnier; D Fauvet; G Vassal; M Kujas; A Bernheim
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

View more
  9 in total

Review 1.  Genetic basis of intramedullary spinal cord tumors and therapeutic implications.

Authors:  A T Parsa; A J Fiore; P C McCormick; J N Bruce
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion.

Authors:  Antonio Pizzuti; Irene Bottillo; Francesca Inzana; Valentina Lanari; Francesca Buttarelli; Isabella Torrente; Anna Teresa Giallonardo; Alessandro De Luca; Bruno Dallapiccola
Journal:  Neurogenetics       Date:  2011-03-02       Impact factor: 2.660

Review 3.  Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.

Authors:  Sebastian Laycock-van Spyk; Nick Thomas; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

4.  Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.

Authors:  D Kaufmann; R Müller; B Bartelt; M Wolf; K Kunzi-Rapp; C O Hanemann; R Fahsold; C Hein; W Vogel; G Assum
Journal:  Am J Hum Genet       Date:  2001-10-18       Impact factor: 11.025

5.  Neurofibromatosis type I: spinal neoplasia without symptoms.

Authors:  Sheffali Gulati; Surbhi Leekha; Arun K Gupta; Veena Kalra
Journal:  Indian J Pediatr       Date:  2004-09       Impact factor: 1.967

6.  The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas.

Authors:  Meena Upadhyaya; Gill Spurlock; Lan Kluwe; Nadia Chuzhanova; Emma Bennett; Nick Thomas; Abhijit Guha; Victor Mautner
Journal:  Neurogenetics       Date:  2009-02-17       Impact factor: 2.660

7.  Spinal neurofibromatosis with NF1 mutation in a classic neurofibromatosis type 1 family: A case report and literature review.

Authors:  Zeqian Ning; Zhiqian Yang; Gaofei Chen; Wenjiao Wu; Longshuang He; Yesheng Sun; Dongpeng Cai; Wei Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-11-11       Impact factor: 2.183

8.  Case report: Bilateral spinal neurofibromatosis.

Authors:  Ali Baradaran Bagheri; Sepehr Aghajanian; Aliasghar Taghi Doulabi; Mehdi Chavoshi-Nejad; Somayeh Sorouredin Abadi
Journal:  Front Neurol       Date:  2022-08-12       Impact factor: 4.086

9.  Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis.

Authors:  Emma Mm Burkitt Wright; Emma Sach; Saba Sharif; Oliver Quarrell; Thomas Carroll; Richard W Whitehouse; Meena Upadhyaya; Susan M Huson; D Gareth R Evans
Journal:  J Med Genet       Date:  2013-06-28       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.